ArticleAmerican journal of cancer research2024

The ascendancy of eosinophil counts in non-small cell lung cancer: a potential marker for predicting response and survival under nivolumab treatment.

Mehmet Fatih Ozbay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.